RNA interference offers promising antiviral methods to minimise nodovirus
outbreaks in aquaculture
Following on from the talk by Leigh
Owens and the recent complementary lecture by Colin, this research used interfering
RNA (RNAi) to assess its effectiveness of reducing mortality from white tail
disease (WTD) in giant freshwater prawns, Macrobrachium
rosenbergii, using redclaw crayfish, Cherax
quadricarinatus as a model organism.
Global demand for seafood is
increasing and with intensive farming comes disease. WTD has lead to mass mortalities in prawn
hatcheries the world over, causing economic problems and loss in
production. M. rosenbergii nodavirus (MrNV) has been identified as the causative
agent of WTD and has caused 100% mortality in hatcheries within one week of the
first clinical signs in the hosts.
RNAi is the sequence-specific degradation of
complementary mRNA using small, functional pieces of double stranded RNA
(dsRNA) to target specific genes. It has
been used as an antiviral mechanism, making it possible to knock-down specific viral
genes and limiting any off-target effects.
This experiment targeted protein
B2 of MrNV, which inhibits the degradation of viral RNA that would normally
occur in the host cells. Sequence
specific RNAi was therefore used to silence the production of protein B2 by
degrading viral mRNA – basically an arms race between virus and host cell.
MrNV from infected M. rosenbergii was homogenised with
phosphate buffered saline (PBS) and injected into select C. quadricarinatus. Sequence
specific RNAi (targeting protein B2), along with control RNAi (non-specific), was
designed and injected into select animals in a cross-over experimental design,
also controlling for exposure to MrNV and RNAi by using placebo treatments and PBS. All experimental animals, unless mortality occurred
during the trial, were sacrificed at the end of 60 days. RNA was extracted from C. quadricarinatus muscle for qPCR analyses and tissue sections prepared
for histopathological analysis.
Invertebrates have no acquired immunity
and RNAi is important for antiviral innate immunity. Only specific dsRNA to protein
B2 was effective in affording increased antiviral defence against MrNV
infection in focal C. quadricarinatus
(10% mortality) compared with high mortality (60%) and clinical signs
consistent with MrNV infection reported in the control RNAi group (see Fig. 1).
The authors note that injection of
RNAi + MrNV did not reduce the average viral titre in comparison to the control
RNAi + MrNV group, contrasting their results to a similar study in crickets
that reported a 10-fold reduction in viral titres (La Fauce & Owens, 2009). An alternative method of delivering sequence
specific dsRNA may yield lower viral counts, for example including it in feeds
via a bacterial plasmid. This may also
allow viable scale up for commercial use and offer an alternative to phage
therapy (see Sanket’s recent posts). In Leigh’s
talk, he stated that his group has had difficulty in scaling up quantities for
phage therapy to be effective outside of laboratory conditions and considers
RNAi a more promising viral control technique.
Inclusion of plasmid contained sequence specific dsRNA in commercial feeds
may still offer antiviral protection to the prawns, whilst maintaining its
select target (eg. the virus) and minimising other undesirable, off target effects. It will be interesting to see where this
promising technique leads, although further long-term, transgenerational
research would benefit here, to gain a better understanding of potential
long-term impacts this may have.
Hayakijkosol, O., & Owens, L. (2012). B2 or not B2: RNA interference
reduces (Macrobrachium rosenbergii) nodavirus
replication in redclaw crayfish (Cherax
quadricarinatus). Aquaculture, 326, 40-45.
No comments:
Post a Comment